Christina Price, MD
Associate Professor of Medicine (Allergy & Immunology); Clinical Chief of Allergy and Immunology, Rheumatology, Allergy, & Immunology; VA Medical Center Section Chief, Allergy and Clinical Immunology
Research & Publications
Biography
News
Research Summary
immune deficiency in autoimmunity
immunotoxicity in patients receiving checkpoint inhibitor
Coauthors
Selected Publications
- Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse EventsBrongiel S, Rychalsky K, Luon D, Johnson A, Price C, Abdelghany O. Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events. Annals Of Pharmacotherapy 2022, 57: 148-155. PMID: 35656843, DOI: 10.1177/10600280221094330.
- Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant eraWang SY, Juthani PV, Borges KA, Shallow MK, Gupta A, Price C, Won CH, Chun HJ. Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era. The Lancet Microbe 2021, 3: e4-e5. PMID: 34901896, PMCID: PMC8641954, DOI: 10.1016/s2666-5247(21)00306-2.
- Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First DoseKrantz MS, Kwah JH, Stone CA, Phillips EJ, Ortega G, Banerji A, Blumenthal KG. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Internal Medicine 2021, 181: 1530-1533. PMID: 34309623, PMCID: PMC8314170, DOI: 10.1001/jamainternmed.2021.3779.
- Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation supportKaman K, Azmy V, Chichra A, Britto-Leon C, Price C. Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support. Respiratory Medicine Case Reports 2021, 33: 101376. PMID: 33680800, PMCID: PMC7925237, DOI: 10.1016/j.rmcr.2021.101376.
- Allergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 PandemicAzmy V, Kaman K, Price C. Allergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 Pandemic. Journal Of Allergy And Clinical Immunology 2021, 147: ab114. PMCID: PMC7849596, DOI: 10.1016/j.jaci.2020.12.418.
- Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19Azmy V, Kaman K, Tang D, Zhao H, Dela Cruz C, Topal JE, Malinis M, Price CC. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19. Journal Of Clinical Immunology 2021, 41: 738-747. PMID: 33459964, PMCID: PMC7812117, DOI: 10.1007/s10875-020-00949-6.
- Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 diseaseZhou Z, Price CC. Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease. Expert Opinion On Investigational Drugs 2020, 29: 1407-1412. PMID: 33094669, DOI: 10.1080/13543784.2020.1840549.
- Optimizing Care for Patients With Adverse Events From Immunotherapeutics.Sheehan K, Price C, Hafez N. Optimizing Care for Patients With Adverse Events From Immunotherapeutics. The Cancer Journal 2020, 26: 537-542. PMID: 33298725, DOI: 10.1097/ppo.0000000000000492.
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical OutcomesPrice CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes. CHEST Journal 2020, 158: 1397-1408. PMID: 32553536, PMCID: PMC7831876, DOI: 10.1016/j.chest.2020.06.006.
- Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patientsDavis MW, McManus D, Koff A, Jaszczur GR, Malinis M, Dela Cruz C, Britto CJ, Price C, Azmy V, Kaman K, Gaston D, Early K, DeWitt M, Song JS, Ortiz C, Juthani-Mehta M, Topal JE. Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients. Infection Control And Hospital Epidemiology 2020, 41: 1335-1337. PMID: 32507113, PMCID: PMC7308631, DOI: 10.1017/ice.2020.281.
- Association of various primary antibody deficiencies with unique clinical manifestations and T cell profiles.Shin J, Liauw D, Siddiqui S, Chung E, Price C, Kang I. Association of various primary antibody deficiencies with unique clinical manifestations and T cell profiles. Journal Of Allergy And Clinical Immunology 2020, 145: ab217. DOI: 10.1016/j.jaci.2019.12.257.
- Subtle But Clinically Significant: A Review of Antibody Deficiency in AdultsHarada K, Price C. Subtle But Clinically Significant: A Review of Antibody Deficiency in Adults, Clin Pulm Med. 26(3):71-75 May 2019
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjectsSchwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà -Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects. Journal Of Allergy And Clinical Immunology 2018, 142: 1932-1946. PMID: 29729943, PMCID: PMC6215742, DOI: 10.1016/j.jaci.2018.02.055.
- Mimics of AngioedemaHirsh J, Price C. Mimics of Angioedema. Journal Of Allergy And Clinical Immunology 2016, 137: ab247. DOI: 10.1016/j.jaci.2015.12.892.
- Diagnosis of Multicentric Castleman's Disease: An Evaluation of a Patient with PolygammopathyDatta R, Price C. Diagnosis of Multicentric Castleman's Disease: An Evaluation of a Patient with Polygammopathy. Journal Of Allergy And Clinical Immunology 2016, 137: ab227. DOI: 10.1016/j.jaci.2015.12.875.
- Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab—for how long?Barmettler S, Price C. Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab—for how long? Journal Of Allergy And Clinical Immunology 2015, 136: 1407-1409. PMID: 26277594, DOI: 10.1016/j.jaci.2015.06.035.
- 444. One-Time Gene Therapy to Prevent Peanut-Induced AnaphylaxisPagovich O, Wang B, Price C, Jose C, Kaminsky S, Chiuchiolo M, Crystal R. 444. One-Time Gene Therapy to Prevent Peanut-Induced Anaphylaxis. Molecular Therapy 2015, 23: s176. DOI: 10.1016/s1525-0016(16)34053-9.
- Profoundly Low Immunoglobulins, Lymphopenia, Thymoma and No InfectionsCatanzaro J, Lee A, Price C. Profoundly Low Immunoglobulins, Lymphopenia, Thymoma and No Infections. Journal Of Allergy And Clinical Immunology 2015, 135: ab15. DOI: 10.1016/j.jaci.2014.12.982.
- Expansion Of Circulating T Follicular Helper Cells In CVID Patients With Autoimmune CytopeniasRomberg N, Hsu I, Price C, Cunningham-Rundles C, Meffre E. Expansion Of Circulating T Follicular Helper Cells In CVID Patients With Autoimmune Cytopenias. Journal Of Allergy And Clinical Immunology 2014, 133: ab162. DOI: 10.1016/j.jaci.2013.12.586.
- Defective Peripheral B Cell Tolerance In Alps Patients With Fas MutationsPrice C, Rao V, Danielian S, Meffre E. Defective Peripheral B Cell Tolerance In Alps Patients With Fas Mutations. Journal Of Allergy And Clinical Immunology 2011, 127: ab226. DOI: 10.1016/j.jaci.2010.12.900.